(Press-News.org) CHICAGO --- Itch torments its sufferers and can be as debilitating as chronic pain.
But it's a hard symptom to measure -- particularly for the 10 million U.S. children with atopic dermatitis, also known as eczema. They can't always verbalize or quantify their suffering via a survey or scale.
It can also be difficult to objectively measure itch for adults with liver disease, kidney disease and certain cancers who experience its symptoms.
So, it's hard to track how well treatments and drugs are working.
But now there is a soft, wearable sensor that actually quantifies itch by measuring scratching when placed on the hand developed by Northwestern University scientists. While it was tested in patients with atopic dermatitis, it can be used in any condition that causes itch. The novel sensor can support clinical trials for new treatments, track treatment response and monitor for disease worsening -- all in the home setting.
This is the first sensor able to capture all forms of scratching -- finger, wrist and elbow motion related. It also is the first validated in a pediatric population where conditions like atopic dermatitis are the most common.
"Itch torments so many patients across so many conditions. It can be as debilitating as chronic pain," said lead author Dr. Shuai "Steve" Xu, assistant professor of dermatology and of pediatrics at Northwestern University Feinberg School of Medicine. "If we're able to quantify scratching accurately, then we have the ability to objectively quantify itching. This is really important in patients -- like children -- who can't always verbalize or quantify their suffering."
The paper will be published April 30 in Science Advances.
Xu also is an assistant professor of biomedical engineering at McCormick School of Engineering and Applied Science and medical director of the Querrey Simpson Institute for Bioelectronics, both at Northwestern.
About 10 million U.S. children have atopic dermatitis. The hallmark symptom is itch leading to sleep disturbance, poor neurocognitive development and, on average, a full night of sleep lost per week.
"Atopic dermatitis is so much more than just itchy skin," Xu said. "It is a devastating disease that causes tremendous suffering worldwide. The quality of life of severe atopic dermatitis (not only for the child but also the parent) is equivalent to many life-threatening diseases.
"Patients with atopic dermatitis are 44% more likely to report suicidal thoughts as a result of the itch compared to controls. Thus, the ability to quantify their symptoms is really important to help new drugs get approved, but also support their day to day lives. In some ways -- it's like measuring glucose for diabetes...measuring itching in an atopic dermatitis patient may be just as important."
"This is an exciting time for children and adults with atopic dermatitis -- or eczema -- because of the flurry of activity in developing new therapeutics," said Dr. Amy Paller, chair of dermatology at Northwestern. "Nothing is more important to measure a medication's effectiveness for eczema than itch, the symptom that both defines eczema and has the greatest impact on quality of life. This sensor could play a critical role in this regard, especially for children."
In addition, clinicians and parents have the ability to track how well itch is being controlled in patients at home to monitor for treatment response, as well as early signs of worsening disease, Xu said.
This sensor marries advances in soft, flexible electronics that wrap seamlessly around the hand with machine learning algorithms that specifically identifies scratching without being tricked by similar motion-related movements (e.g. hand waving). The sensor measures both low-frequency motion and high-frequency vibrations from the hand to significantly improve accuracy compared to wrist-watch tools.
The sensor was accepted into the Food and Drug Administration's Drug Discovery Tool program. This program allows novel devices like this sensor to be qualified to aid in the approval of new drugs.
The study was conducted in two parts. The first part involved training the sensor to pick up scratching in healthy adults doing voluntary scratching behaviors. The second part tested the sensors on pediatric patients with atopic dermatitis. Parents set up an infrared camera to serve as the "gold standard". The algorithm and sensor were then used to count scratches in this pediatric patient population. More than 300 hours of sleep data was manually reviewed and scored for scratching and linked to the sensors.
INFORMATION:
Other Northwestern authors are Keum San Chun, Youn J. Kang, Jong Yoon Lee, Morgan Nguyen, Brad Lee, Rachel Lee, Han Heul Jo , Emily Allen , Hope Chen , Jungwoo Kim , Lian Yu , Xiaoyue Ni , KunHyuck Lee , Hyoyoung Jeong, JooHee Lee, Yoonseok Park, Ha Uk Chung, Alvin W. Li, Peter A. Lio, Albert Yang, Anna B. Fishbein and John A. Rogers.
The research was supported by FDA grant U01FD007001), Pfizer ASPIRE award and Novartis Pharmaceuticals. The work was also supported by the Querrey Simpson Institute for Bioelectronics at Northwestern University.
Boston, MA (April 30, 2021) - A new study, presented today at the AATS 101st Annual Meeting, shows significant reduction in post-operative use of Schedule II opioids for pain management following robotic surgery. To address the on-going issues of opioid overuse and abuse, the study aimed to examine the use of painkillers in Enhanced Recovery After Thoracic Surgery (ERATS) protocols and determine the impact of alternative pain management approaches on clinical outcomes.
An Institutional Review Board-approved retrospective analysis of a prospectively maintained ...
Boston, MA (April 30, 2021) - A new set of guidelines, developed by AATS and ESTS (European Society for Thoracic Surgery) presented today at the AATS 101st Annual Meeting, recommends a 30-day course of Venous Thromboembolism (VTE) prophylaxis post-discharge for patients undergoing surgical resection for lung or esophagus cancer. The AATS and ESTS formed a multidisciplinary guideline panel that included broad membership to minimize potential bias when formulating recommendations. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic reviews and meta-analyses. The results are endorsed by the American Society of Hematology (ASH) and the International Society ...
Global sea level rise associated with the possible collapse of the West Antarctic Ice Sheet has been significantly underestimated in previous studies, meaning sea level in a warming world will be greater than anticipated, according to a new study from Harvard researchers.
The report, published in Science Advances, features new calculations for what researchers refer to as a water expulsion mechanism. This occurs when the solid bedrock the West Antarctic Ice Sheet sits on rebounds upward as the ice melts and the total weight of the ice sheet decreases. The bedrock sits below sea level so when it lifts, it pushes water from the surrounding area into the ocean, adding to global ...
An international research group led by Prof. WANG Bo and Prof. SHI Gongle from the Nanjing Institute of Geology and Palaeontology of the Chinese Academy of Sciences (NIGPAS) collected approximately 25,000 fossil-containing amber samples and about 5,000 fossil plants in Zhangpu County, Fujian Province, southeast China from 2010 to 2019.
Their findings were published in Science Advances on April 30.
The Zhangpu biota, including amber biota and co-occurring megafossils, is the richest tropical seasonal rainforest biota discovered so far. It reveals that ...
Researchers from the Carl R. Woese Institute for Genomic Biology in collaboration with scientists at Oxford University have published a paper in Cell reporting the function of LanCL proteins. These proteins are found in eukaryotic cells but their function was previously unknown. The study is the first step towards understanding the importance of these ubiquitous proteins.
Bacteria contain enzymes called LanC that are capable of producing small proteins called lanthipeptides, which are characterized by the addition of a thiol group to a modified serine or threonine amino acid. Similar proteins--called LanC-like ...
UNIVERSITY PARK, Pa.-- Not all public figures are equally beloved, and sometimes when more controversial celebrities get sick, it may negatively affect people's health intentions. In a study of people's reactions to radio host Rush Limbaugh's announcement of a lung cancer diagnosis and Kentucky Sen. Rand Paul's announcement of a diagnosis of COVID-19, researchers at Penn State found that those who took pleasure in their misfortune were themselves less likely to take steps to prevent lung cancer or COVID-19.
"Schadenfreude is the emotion of feeling pleasure in another's misfortune," said Jessica Gall Myrick, associate professor of media studies. "In our study, after learning the news of a politician's ...
Passed in 2018, the First Step Act sought to address re-entry challenges for inmates in the federal prison system. The legislation called for developing an assessment tool to identify inmates for release who had the lowest likelihood of recidivism. A new study assessed how the tool was developed and is used, finding that a greater proportion of inmates could reduce their risk and become eligible for early release over time if they participated in a re-entry program and did not incur infractions. This finding has implications for efforts to reduce prison populations during the COVID-19 pandemic.
The study, by researchers at the University of Nebraska ...
eNeuro is publishing a special collection of commentaries on April 30, 2021 on the neuroscience documentary In Silico. The collection, titled "Epistemological Lessons from the Blue and Human Brain Projects," features reactions to the documentary from leading neuroscientists as well as a discussion on brain modelling and massive research collaborations in general.
Noah Hutton's In Silico follows neuroscientist Henry Markram and his attempt to develop a computer model of the brain. The collaboration, called The Human Brain Project, received €1 billion in funding and pledged to build a full model within ten years. The documentary chronicles Markram and ...
WASHINGTON, D.C, (April 30, 2021) - An analysis of a new international registry reveals benefits of using a longer covered stent for interventional procedures in congenital heart disease patients with Sinus Venosus Atrial Septal Defect (SVASD). The study was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
SVASD is a rare adult congenital heart disease which permits shunting of blood from the systemic to the pulmonary circulation , causing excessive blood flow to the lungs. Until now, open heart surgical repair was the gold standard approach to dealing with this condition but is necessarily invasive. Covered stent implantation is ...
WASHINGTON, D.C., (April 30, 2021) - New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function. The results of this study are being presented as late-breaking clinical science today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
About 40,000 infants are born with CHD every year in the United States ...
